Announcements Trials
Browse Landscape

Phase

Phase 2/3 1Phase 2 1

Status

Unknown 2

Sponsor Class

OTHER 2OTHER_GOV 1

Study Type

Interventional 2

Sponsor

Cancer Type

Breast 2

Conditions

Carcinoma, Non-Small-Cell Lung 15Nasopharyngeal Carcinoma 8Lung Neoplasms 7Uterine Cervical Neoplasms 3Melanoma 3Esophageal Squamous Cell Carcinoma 3Colorectal Neoplasms 3Nasopharyngeal Neoplasms 2Lymphoma, T-Cell 2Breast Neoplasms 2Stomach Neoplasms 1Sarcoma 1Recurrence 1Radiation Injuries 1Quality of Life 1Osteosarcoma 1Non-squamous Non-small Cell Lung Cancer 1Neuroblastoma 1Lymphoma, T-Cell, Peripheral 1Head and Neck Neoplasms 1Gastrointestinal Neoplasms 1Esophageal Neoplasms 1Esophageal 1Carcinoma, Hepatocellular 1Bone Neoplasms 1Advanced Pancreatic Cancer 1Advanced Gastric Cancer 1Advanced Colorectal Cancer 1

Interventions

Cyclophosphamide 361Trastuzumab 352Paclitaxel 304Docetaxel 272Capecitabine 222Letrozole 221Carboplatin 185Doxorubicin 181Tamoxifen 157Radiotherapy 154Epirubicin 145Fulvestrant 143Anastrozole 139Surveys and Questionnaires 133Exercise 128pertuzumab 113Vinorelbine 110Blood Specimen Collection 109exemestane 106palbociclib 104Bevacizumab 104pembrolizumab 98Magnetic Resonance Spectroscopy 97Albumin-Bound Paclitaxel 87Gemcitabine 84Drug Therapy 83Lapatinib 78130-nm albumin-bound paclitaxel 72Neoadjuvant Therapy 71Cisplatin 69

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
OTHER × Breast Neoplasms × endostar protein × Clear all
NCT01907529 2019-08-09

TENDENCY

Hebei Medical University Fourth Hospital

Phase 2/3 Unknown
300 enrolled
Breast

Breast Neoplasms

NCT03907098 2019-04-08

Endostar in Combination With Chemotherapy in HER-2 Negative Advanced Breast Cancer

Zhejiang Cancer Hospital

Phase 2 Unknown
50 enrolled
Breast

Breast Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡